• Policy
• The KDCA has set aside ₩299.2 billion for COVID-19 tx
• by Kim, Jung-Ju Dec 16, 2021 05:51am

• Policy
• Exempt PVA for drugs with claims less than ₩10 billion
• by Lee, Hye-Kyung Dec 16, 2021 05:51am

• Policy
• Janssen keeps the Tylenol name for its imported product
• by Lee, Tak-Sun Dec 16, 2021 05:51am

• Policy
• Moderna Korea has obtained permission for sales
• by Lee, Tak-Sun Dec 15, 2021 05:52am

• Policy
• The project to expand the age of NIP will be implemented
• by Lee, Jeong-Hwan Dec 14, 2021 05:58am

• Policy
• Promotion of legislation to expand HPV vaccine NIP to boys
• by Lee, Jeong-Hwan Dec 14, 2021 05:57am

• Policy
• A clinical study on CAR-T tx at SNUH has been approved
• by Kim, Jung-Ju Dec 14, 2021 05:56am

• Policy
• 241 items of the impurity detected Losartan were recovered
• by Lee, Tak-Sun Dec 14, 2021 05:56am

• Policy
• Phase III for Amivantamab-Lazertinib was approved
• by Lee, Tak-Sun Dec 13, 2021 05:57am

• Policy
• MFDS is considering changing the permission of Remdesivir
• by Lee, Tak-Sun Dec 13, 2021 05:56am